Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wulff Group Plc’s Interim Report for January 1 – March 31, 2021

INTERIM REPORT  APRIL 26, 2021 AT 10.00 A.M. This is a summary of Wulff Group Plc’s Interim Report for January-September 2021. Wulff Group’s Interim Report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi.  Netsales increased by 4% and operating profit doubled 1.1.-31.3.2021 BRIEFLY · Net sales totalled EUR 15.3 million (14.7), increased by 4.0%. · EBITDA and comparable EBITDA were EUR 0.9 million (0.7). · Operating profit and comparable operating profit (EBIT) amounted to EUR 0.6 million

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q1 2021 results

2020 Bulkers Ltd. will release its financial results for the first quarter of 2021 on Wednesday, April 28, 2021. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://edge.media-server.com/mmc/p/nvjvh4np or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/ Conference Call: Dial in

AcuCort progresses into a new phase and strengthens the commercialization team

AcuCort AB (Spotlight Stock Market: ACUC) has employed Louise Harting as Project Manager. The company has entered a new stage in the preparatory work for the upcoming commercialization and thus needs a dedicated and expanded resource. Louise has taken up the new position with a focus on market registration of the drug ISICORT®.Louise Harting holds a master degree (Msc) in International Business from Copenhagen Business School. She has experience of international product launches in the pharmaceutical industry from, among others, Novo Nordisk. In her role as Project Manager at AcuCort, her

Otello Corporation ASA – Buyback of shares

Oslo, 26 April 2021 In reference to the buyback program announced 7 April 2021, Otello Corporation ASA has purchased 267 954 of its own shares. The shares were purchased at an average price of NOK 31,4875 per share. Date                      Number of shares            Weighted average price 19 April 21           54 542                                   31,6685 20 April 21           60 000                                   31,4632 21 April 21           50 912                                   31,1761 22 April 21           57 500                                   31,4757

Proposal for election of two new members of the Board of Directors

Hørsholm, Denmark, April 26, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that Gitte L. Pedersen does not seek re-election to the Board of Directors at the forthcoming Annual General Meeting on May 26, 2021, and that two new members, Karin Garre and Sara Sande, are proposed for election. Thus, it is proposed to re-elect Jakob Knudsen, Martin Roland Jensen and Allan Rosetzsky and to elect Karin Garre and Sara Sande as new directors and to re-elect Martin Roland Jensen as chairman of the board.Chairman of the Board Martin Roland Jensen comments “I would like to take

Archer signs offer letter to acquire DeepWell

Hamilton, Bermuda (April 26, 2021) Archer Limited is pleased to announce that we have signed an offer letter with Moreld laying out principle terms to purchase 100% of the shares in Deepwell AS (“DeepWell”).  The contemplated transaction is subject to due diligence, negotiation of the transaction documentation, closing conditions and regulatory approvals. DeepWell is a leading Norwegian well intervention company focused on mechanical wireline and cased hole logging services. Headquartered in Avaldsnes, Norway, DeepWell had approximately 200 employees and a revenue of NOK 355 million

New CFO starts at Resurs - internal recruitment focusing on Resurs’s development as a sustainable financial company

Resurs has appointed Sofie Tarring Lindell as the new CFO & Head of IR. Sofie is currently Head of IR & Group Control and will assume her new position on 1 May 2021. For the transformation journey that Resurs has commenced, Sofie will focus on profitable growth and supporting the operations to become a competitive, digital and sustainable company.The new CFO & Head of IR of the Resurs Group will be Sofie Tarring Lindell. She will assume her new position on 1 May 2021, succeeding interim CFO Claes Wenthzel. Sofie joined Resurs in 2014 and has successively developed in various positions at

Crunchfish’s message at OMFIF’s inaugural DMI symposium - Will banks need to change their infrastructure as cash becomes digitized?

Crunchfish will be exhibiting and presenting at OMFIF’s inaugural Digital Monetary Institute symposium and challenge the prevailing perception that bank infrastructure must change as cash becomes digitized. Cash can either be digitized as a new currency, using existing payment systems, or as a new format, requiring large investments in the banking sector. In the iconic scene from the 1999 blockbuster The Matrix, Neo realised that he must choose between the red and the blue pill. Central Banks have a fundamental choice of how to digitize cash that will have an enormous impact on the bank

Notice of Annual General Meeting in ExpreS2ion Biotech Holding AB

The shareholders of ExpreS2ion Biotech Holding AB, reg. no. 559033-3729, (the "Company"), are hereby convened to the annual general meeting to be held on Wednesday 26 May 2021.This is an unofficial translation of a notice to the Annual General Meeting in ExpreS[2]ion Biotech Holding AB, originally drafted in Swedish. In case of any discrepancies between the Swedish original and this translation, the Swedish version shall prevail.  Information with respect to the coronavirus The Company is mindful of the health and well-being of its shareholders and employees. It´s important for the

Annual General Meeting in Oncopeptides AB (publ)

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Annual General Meeting to be held on Wednesday May 26, 2021. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting

Asetek Launches Share Buyback Program to Cover Employee Stock Options

April 26, 2021 - Asetek today announced the launch of a share buyback program. The share buyback will be conducted under the safe harbor provisions of EU Regulation 2273/2003. Section 3-12 of the Norwegian Securities Trading Act implements the EU Commission Regulation (EC) No 2273/2003 on exemptions for buy-back programs and stabilization of financial instruments in Norwegian law. The buyback program will be carried out by market purchases in accordance with the authorization granted by the annual general meeting to the Board of Directors on April 22, 2021. Shares purchased under the

Volvo Group invests in Designwerk Technologies AG to complement electromobility capabilities

Volvo Group has signed definitive agreements to acquire 60 percent of Designwerk Technologies AG, an engineering company in Switzerland, that develops and sells electromobility products and engineering services within electromobility eco-systems. By investing in Designwerk Technologies, the Volvo Group will complement its current capabilities when it comes to niche products and solutions.“Designwerk Technologies have strong competencies within electromobility, focused on developing, prototyping and producing low volume niche products in the entire industrial electromobility spectrum, which

Alfa Laval to pioneer ground-breaking, sustainable heat exchanger recycling

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – in partnership with Stena Recycling, leading in recycling and circular solutions, is to launch a ground-breaking business model for sustainable and environmentally efficient recycling of heat exchangers, enabling up to 100 percent metal regeneration. The partnership is a first step towards a circular approach to the company’s product portfolio, and an important part of Alfa Laval’s commitment to become carbon neutral by 2030.The goal of this new initiative is twofold: Firstly, to encourage replacement

New CFO starts at Resurs - internal recruitment focusing on Resurs’s development as a sustainable financial company

Resurs has appointed Sofie Tarring Lindell as the new CFO & Head of IR. Sofie is currently Head of IR & Group Control and will assume her new position on 1 May 2021. For the transformation journey that Resurs has commenced, Sofie will focus on profitable growth and supporting the operations to become a competitive, digital and sustainable company.The new CFO & Head of IR of the Resurs Group will be Sofie Tarring Lindell. She will assume her new position on 1 May 2021, succeeding interim CFO Claes Wenthzel. Sofie joined Resurs in 2014 and has successively developed in various positions at

Finnish Lapland combats Zoom fatigue

Add the silence and serenity of Finnish Lapland to your next online meetingOnly in Lapland, the official travel marketing channel for Finnish Lapland, has announced that they are offering images inspired by their Sound of Lapland  – SCAPES album for use in Microsoft Teams, Zoom, Google Meet and other online meeting platforms. The inspirational background images allow users to replace their office, bedroom or living room walls with relaxing Arctic landscapes. Only in Lapland’s hope is that this small measure can help make video calls a

Selumetinib recommended for approval in the EU by CHMP as the first medicine for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas

26 April 2021 07:10 BST Selumetinib recommended for approval in the EU by CHMP as the first medicine for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas Recommendation based on the SPRINT Phase II trial, which showed selumetinib reduced tumour volume in children AstraZeneca and MSD's selumetinib has been recommended for conditional marketing authorisation in the European Union (EU) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in paediatric patients with neurofibromatosis type 1 (NF1) aged three years and above.[1] NF1 is

Tagrisso adjuvant receives positive CHMP opinion

26 April 2021 07:05 BST Tagrisso recommended for approval in the EU by CHMP for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer Opinion based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80% AstraZeneca's Tagrisso (osimertinib) has been recommended for marketing authorisation in the European Union for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete

A sustainable and efficient detergent for chamber washing in the machining industry - Kiilto Pro Parts Cleaner

Eco-friendliness is a growing trend, and the popularity of green products keeps increasing. Sustainability will be a prerequisite for successful operation also in technology industries. In response to this demand, Kiilto has developed Kiilto Pro Parts Cleaner, a new sustainable, and efficient detergent for chamber washing. The new detergent has been granted the Nordic Swan Ecolabel.The machining industry consumes considerable amounts of washing detergents, and the detergents thus play a significant role in terms of both eco-friendliness and costs. A high-quality detergent has a direct

Metsä Fibre and Flootech sign contract on delivery of efficient water plant for Kemi bioproduct mill

Metsä Fibre press release 26.4.2021Metsä Fibre, part of Metsä Group, and Flootech have signed a contract on the delivery of a water plant for the bioproduct mill being constructed in Kemi, Finland. The delivery includes the water plant itself as well the installation and commissioning of its process equipment. The delivery has a very high degree of Finnish origin – more than 90 per cent – and it will provide dozens of person-years of work in Finland at Flootech. Flootech is a Finnish water technology company that provides high-tech water and wastewater treatment solutions developed in

Neste’s renewable fuel oil reduces greenhouse gas emissions from Lumene’s manufacturing process

Neste Corporation, Press Release, 26 April 2021 at 9 a.m. (EET) Finnish cosmetics company Lumene introduces Neste MY Non-Road Diesel™ at its factory in Kauklahti, Espoo, Finland, during this spring. The renewable fuel oil replaces the fossil fuel oil previously used at the factory. By switching to a new renewable solution launched by Neste in early 2021, Lumene is able to reduce the greenhouse gas emissions from the production of process steam needed in the product manufacturing by up to 90%* compared to using fossil fuel oil.  “Sustainability is one of Lumene’s core values,

Interim report January - March 2021

Increased profitable growth thanks to strong recovery and strict cost control.Group Demand was favorable in most of the Group’s customer segments and geographic regions during the first quarter. Order bookings and sales increased both sequentially compared with the fourth quarter and compared with the year-earlier period. The operating margin improved significantly thanks to a competitive cost base and a favorable product and segment mix. Combined, this led to the strongest results in the Group’s history. Our cash flow was also stronger than in previous first quarters and was positively

Agreement to acquire Bentley discovery

EnQuest PLC, 26 April 2021 EnQuest signs SPA for 100% equity interest in the Bentley discovery EnQuest PLC (together with its subsidiaries, 'EnQuest'), an independent oil and gas production and development company listed on the London and Stockholm stock exchanges (ENQ.L and ENQ.ST), is pleased to announce it has signed a Share Purchase agreement ('SPA') with Whalsay Energy Holdings Limited ('Whalsay') to purchase their entire 100.00% equity interest in the P1078 licence containing the proven Bentley heavy-oil discovery. This discovery is within c.15 kilometres of the Group's existing

Completion of Phase 1 Platforms

26 April 2021   Independent Oil and Gas plc   Mechanical Completion of Phase 1 Platforms   Independent Oil and Gas plc (IOG, or the Company), (AIM: IOG.L), the UK gas company targeting growth and high returns via an infrastructure-led hub strategy, is pleased to announce that it signed off the Blythe and Southwark platforms as mechanically complete earlier this month. Further to achieving this milestone and the arrival of the Noble Hans Deul rig at Elgood in early April, the Company can also confirm that it has now, as planned, fully drawn its bond escrow account into

Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections in healthy infants

26 April 2021 07:00 BST Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections in healthy infants First potential passive immunisation to show protection against RSV in the general infant population The MELODY Phase III trial for nirsevimab met its primary endpoint of a statistically significant reduction in the incidence of medically attended lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) compared to placebo in healthy late preterm and term infants (35 weeks or more) during their first RSV

There are no items matching the current filter
There are no more items matching the current filter
Back to top